6/17/2025

Becaplermin Topical Gel

Products Affected - Description

- Regranex topical gel, Smith & Nephew, 0.01%, 15 gm tube, NDC 50484-0810-15

Reason for the Shortage

- Lynch Regenerative Medicine has acquired Regranex. Smith and Nephew will distribute Regranex through August 2025, or until remaining supply is depleted. After August 2025, Lynch Regenerative Medicine will manufacturer and distribute Regranex.

Available Products

- There is insufficient supply for usual ordering

Estimated Resupply Dates

- Smith and Nephew will distribute Regranex through August 2025, or until remaining supply is depleted. The remaining supply is short dated and in limited supply. Once depleted, product will be unavailable until the new manufacturer, Lynch Regenerative Medicine, has product available.

Updated

Updated June 17, 2025 by Leslie Jensen, PharmD, Drug Information Specialist. Created March 29, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.